[ad_1]
If you are traveling to countries at risk this summer, be careful. Two vaccines to prevent tick-borne encephalitis in children and adults are out of stock at least until the end of July, according to the press release of the National Agency for the Safety of Medicines ( ANSM), that reports Europe 1.
These are vaccines Ticovac 0,25 ml child, more available since July 9, and 0.5ml adult, broken since June 23, manufactured by the Pfizer American laboratory. The provision of these products is not planned before July 30, says the ANSM.
In case of extreme urgency, there are nevertheless "very limited stocks reserved only for urgent medical needs", available on request from the Pfizer laboratory, specifies the latter.
For adults, the vaccine competitor Pfizer, Encépur, laboratories GlaxoSmithKline, is still available in pharmacies, and can be injected from the age of 12 years
Tick-borne encephalitis, what is it?
Tick-borne encephalitis is transmitted by the bite of this arachnid. It can cause serious infections of the brain or spinal cord and meninges.
Vaccination against this viral disease is recommended by the French authorities if you go "in rural or wooded areas in endemic areas (Europe central, eastern and northern, northern central Asia, northern China, northern Japan) from spring to autumn ", including Switzerland, Germany, Sweden, Finland and Greece. On the other hand, it is not obligatory if you remain in the Hexagon.
[ad_2]
Source link
